286 related articles for article (PubMed ID: 21900218)
21. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
22. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
23. Histopathologic classification of adenocarcinoma of the esophagogastric junction.
Baldus SE
Recent Results Cancer Res; 2010; 182():29-38. PubMed ID: 20676869
[No Abstract] [Full Text] [Related]
24. Clinical classification systems of adenocarcinoma of the esophagogastric junction.
Mönig SP; Hölscher AH
Recent Results Cancer Res; 2010; 182():19-28. PubMed ID: 20676868
[No Abstract] [Full Text] [Related]
25. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction.
Posner MC; Gooding WE; Landreneau RJ; Rosenstein MM; Clarke MR; Peterson MS; Lembersky BC
Cancer J Sci Am; 1998; 4(4):237-46. PubMed ID: 9689982
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinoma at the gastroesophageal junction.
Al-Haddad S; Chang AC; De Hertogh G; Grin A; Langer R; Sagaert X; Salemme M; Streutker CJ; Soucy G; Tripathi M; Upton MP; Vieth M; Villanacci V
Ann N Y Acad Sci; 2014 Sep; 1325():211-25. PubMed ID: 25266027
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: Impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy.
DeWitt J; Kesler K; Brooks JA; LeBlanc J; McHenry L; McGreevy K; Sherman S
Dis Esophagus; 2005; 18(1):21-7. PubMed ID: 15773837
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system.
Gertler R; Stein HJ; Langer R; Nettelmann M; Schuster T; Hoefler H; Siewert JR; Feith M
Ann Surg; 2011 Apr; 253(4):689-98. PubMed ID: 21475008
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic therapy of esophago-gastric tumors.
Lambert R
Endoscopy; 1992; 24(1-2):24-33. PubMed ID: 1373114
[No Abstract] [Full Text] [Related]
30. Esophageal carcinoma.
Rustgi AK; El-Serag HB
N Engl J Med; 2014 Dec; 371(26):2499-509. PubMed ID: 25539106
[No Abstract] [Full Text] [Related]
31. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
Wu TT; Chirieac LR; Abraham SC; Krasinskas AM; Wang H; Rashid A; Correa AM; Hofstetter WL; Ajani JA; Swisher SG
Am J Surg Pathol; 2007 Jan; 31(1):58-64. PubMed ID: 17197919
[TBL] [Abstract][Full Text] [Related]
32. Palliative endoscopic dilatation in carcinoma of the esophagus and esophagogastric junction.
Lundell L; Leth R; Lind T; Lönroth H; Sjövall M; Olbe L
Acta Chir Scand; 1989 Mar; 155(3):179-84. PubMed ID: 2472723
[TBL] [Abstract][Full Text] [Related]
33. Current management of carcinoma of the esophagus.
Ellis FH
Compr Ther; 1993; 19(5):214-9. PubMed ID: 7506132
[No Abstract] [Full Text] [Related]
34. Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials.
Sohal DP; Rice TW; Rybicki LA; Rodriguez CP; Videtic GM; Saxton JP; Murthy SC; Mason DP; Phillips BE; Tubbs RR; Plesec T; McNamara MJ; Ives DI; Bodmann JW; Adelstein DJ
Dis Esophagus; 2015; 28(6):547-51. PubMed ID: 24849395
[TBL] [Abstract][Full Text] [Related]
35. [Controversy on classification of cancers of the gastro-esophageal junction and its clinical significance].
Zhang X
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):76. PubMed ID: 16737630
[No Abstract] [Full Text] [Related]
36. Down-staging of an advanced esophageal carcinoma with chemoradiotherapy leading to stent migration necessitating colectomy.
Thuraisingam AI; Hughes ML; Smart HL
Gastrointest Endosc; 2004 Mar; 59(3):457-60. PubMed ID: 14997158
[No Abstract] [Full Text] [Related]
37. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
Cohen DJ; Leichman L
J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
[TBL] [Abstract][Full Text] [Related]
38. Carcinoma of the esophagus. Part 1: Primary therapy.
Minsky BD
Oncology (Williston Park); 1999 Sep; 13(9):1225-32, 1235-6. PubMed ID: 10509320
[TBL] [Abstract][Full Text] [Related]
39. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
40. Esophageal carcinoma after sleeve gastrectomy.
Scheepers AF; Schoon EJ; Nienhuijs SW
Surg Obes Relat Dis; 2011; 7(4):e11-2. PubMed ID: 21126926
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
